Drug Trial Radar · NCT05626855
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
238
Actual
Start
Apr 17, 2023
Primary completion
Nov 1, 2026
Study completion May 2, 2029
Sponsor
- Lead sponsor
- Scholar Rock, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ONYX study is an Open-Label, Multicenter, Extension study that will evaluate the long-term safety and efficacy of Apitegromab in Patients with Type 2 and Type 3 SMA who have completed TOPAZ or SAPPHIRE.
Conditions
- Spinal Muscular Atrophy
- Spinal Muscular Atrophy Type 3
- Spinal Muscular Atrophy Type 2
- SMA
- Neuromuscular Diseases
- Muscular Atrophy
- Atrophy
- Muscular Atrophy, Spinal
- Neuromuscular Manifestations
- Anti-myostatin
Interventions
ApitegromabDrug
Apitegromab (SRK-015) is an investigational, fully human immunoglobulin G4 monoclonal antibody that specifically binds to human proforms (i.e., inactive precursor forms) of myostatin, pro- and latent- myostatin, with high affinity, inhibiting activation of myostatin, a negative regulator of muscle growth and strength.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the long-term safety and tolerability of apitegromab in patients with Type 2 and Type 3 SMATime frame: Up to 6 years
Locations
49 sites in 9 countries. Site status is shown where the registry gives one.
Phoenix Childrens Hospital
Phoenix, Arizona
UCSD Altman Clinical and Translational Research
La Jolla, California
Children's Hospital Los Angeles
Los Angeles, California
Stanford Neuroscience Health Center
Palo Alto, California
Children's Hospital Colorado
Aurora, Colorado
Nemours Biomedical Research
Orlando, Florida
Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Iowa
Iowa City, Iowa
University of Kansas Medical Center
Fairway, Kansas
Johns Hopkins Hospital
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
Helen DeVos Children's Hospital
Grand Rapids, Michigan
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Washington University Medical Campus
St Louis, Missouri
Columbia University Medical Center
New York, New York
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Nationwide Children's Hospital
Columbus, Ohio
Oregon Health & Science University
Portland, Oregon
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
St. Jude Children's Research Hospital
Memphis, Tennessee
University of Texas Southwestern - Pediatric Neurology
Dallas, Texas
University of Utah
Salt Lake City, Utah
Children's Specialty Group PLLC (Children's Hospital of The King's Daughters)
Newport News, Virginia
Seattle Children's Hospital
Seattle, Washington
University of Wisconsin Hospital
Madison, Wisconsin
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
CHR Citadelle
Liège, Belgium
CHRU de Lille - Hpital Jeanne de Flandre
Lille, France
Hopital Trousseau - I-Motion
Paris, France
CHU Toulouse Hopital des Enfants
Toulouse, France
Universitätskinderklinik Bonn, Abteilung für Neuropädiatrie und SPZ
Bonn, Germany
Universitatsklinikum Essen
Essen, Germany
Universitatsklinikum Freiburg
Freiburg im Breisgau, Germany
Klinikum der Universitat Munchen, Dr. von Haunersches Kinderspital, Abteilung fur Kinderneurologie und Entwicklungsneurologie
Munchen, Bayern, Germany
Istituto Giannina Gaslini, Centro Traslazionale di Miologia e Patologie Neurodegenerative
Genova, Italy
UOC NEUROLOGIA E MALATTIE NEUROMUSCOLARI A.O.U Policlinico G. Martino
Messina, Italy
Carlo Besta Neurological Research Institute
Milan, Italy
NeuroMuscular Omnicentre
Milan, Italy
Fondazione Policlinico Universitario A. Gemelli
Roma, Italy
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.